Reviva Pharmaceuticals Holdings, Inc.
Key Metrics
Market Snapshot
About
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for diseases of the central nervous system. The company is advancing its lead candidate brilaroxazine for treatment of schizophrenia, bipolar disorder, and major depressive disorder. Reviva utilizes a novel approach targeting multiple neurotransmitter pathways simultaneously.